Therefore, it stands to reason that GB1107 inhibited galectin-3 expression and attenuated the development of BLM-induced pulmonary fibrosis by suppressing the AKT/GSK3β/β-catenin singling pathway. The gene discussed is LGALS3; the disease is pulmonary fibrosis.